Clovis Oncology : Modification to Rights of Security Holders

Research and Development - General and Administrative 4,321,718 431,103 52,148 Selling Expenses 228,165 13,808-Operating Taxes 28,649 - Other Operating Expenses -- Total Operating Expenses 3,314,185...

Related Keywords

New York ,United States ,Pageonepartone Pageoneparttwo Pagetwopartone Pagetwoparttwo ,Danielw Muehl ,Actuals Limited Assets Current ,Debtor Bank ,Debtor Statements Of Financial Affairs ,Office Equipment ,Clovis Oncology Ireland ,Debtor Name Clovis Oncology Inc ,Actuals Limited Payments To Insiders ,Firm Name Role ,Willkie Farr Gallagher ,Office For United States Trustee ,Clovis Oncology United Kingdom Limited Accounts Receivable ,Jp Morgan ,Morris ,Clovis Oncology United Kingdom Limited Jp Morgan ,Days Clovis Oncology Inc ,Clovis Oncology United Kingdom ,Lab Equpment ,Clovis Oncology Ireland Limited Jp Morgan ,United States Bankruptcy Court District Of Delaware ,Actuals Limited Total Revenue ,Party Cash Receipts Clovis Oncology Inc ,Ducera Partners ,Inter Company Debtor Receivables Inventories ,Clovis Oncology Inc ,Clovis Oncology Ireland Limited Accounts Receivable ,Software Manufacturing Equipment ,Bank Account Information Reporting Period ,Party Cash Disbursements Clovis Oncology Inc ,Clovis Oncology ,Lead Case ,Period Ended ,Industry Classification ,Accrual Basis Cash ,Full Time Employees ,Andrew Mordkoff ,Responsible Party Printed Name ,Presponsible Party ,Periodic Report ,Paperwork Reduction Act ,Name Clovis Oncology ,Cash Receipts ,Disbursements Current Month Cumulative ,Liability Status Current Month ,Assets Sold ,Transferred Current Month Cumulative ,Income Statement ,Current Month Cumulative ,Professional Fees ,Aggregate Total ,Willkie Farr ,Tunne Local Counsel ,Aggregate Total Itemized Breakdown ,Postpetition Taxes Current Month Cumulative ,Individual Chapter ,Domestic Support Obligations ,Domestic Support Obligation ,Privacy Act Statement ,United States Trustee ,Executive Office ,Case Files ,Associated Records ,Monthly Operating Report ,Responsible Party Executive Vice President ,Chief Financial Officer ,Three Pagefour ,Disbursements Reporting Period ,Third Party Cash Disbursements Clovis Oncology ,Oncology United Kingdom Limited ,Oncology Ireland Limited ,Third Party Cash Receipts Clovis Oncology ,Alixpartners General ,Bank Last ,Description Balance ,Month End ,Fees Account ,Deposits Account ,Total Bank Accounts ,Unaudited Balance Sheet ,Limited Assets ,Current Assets ,Cash Equivalents ,Accounts Receivable ,Interco Receivables ,Intangible Assets ,Non Current Assets ,Current Liabilities ,Accounts Payable ,Accrued Expenses ,Lease Liability Long Term ,Non Current Liabilities ,Common Stock ,Unaudited Statement ,Limited Total Revenue ,Goods Sold ,Operating Taxes ,Operating Expenses ,Operating Profit ,Interest Income ,Asset Sales ,Foreign Currency Translation Adjustments ,Available For Sale Securities ,Reorganization Costs ,Net Income ,Accounts Receivable Reconciliation ,Aging Reporting Period ,Accounts Receivable Aging ,Days Total Trade Accounts Receivable ,Prompt Pay Discounts ,Bad Debts ,Total Current ,Days Clovis Oncology ,Capital Assets Reporting Period ,Limited Net Book Value ,Computer Equipment ,Book Value ,Insiders Reporting Period ,Limited Payments ,Authorized Individual Date ,Executive Vice President ,Chief Financial Officer Printed Name ,Authorized Individual Title ,Authorized Individual ,Bankruptcy Code ,Debtor Statements ,Post Petition Taxes Reporting Period ,